ライフサイエンスコーパス: technetium-99m sestamibi

1 est pain underwent MP imaging with SPECT and technetium-99m sestamibi.

2 The technique involved injecting 20 mCi technetium-99m sestamibi 2 hours before surgery and perf

3 inologist (S.J.M.), who decided to perform a technetium 99m sestamibi ((99m)Tc MIBI) parathyroid scan

4 Technetium-99m-sestamibi activity in the ischemic zone (

5 erfusion images using either thallium-201 or technetium-99m sestamibi, and no previous coronary revas

6 Technetium-99m-sestamibi appears to indicate the extent

7 After injection of 740 MBq technetium 99m sestamibi, craniocaudal and mediolateral

8 s suggest that early perfusion imaging using technetium-99m sestamibi enables reliable risk stratific

9 t ventricular (LV) function from post-stress technetium-99m sestamibi gated SPECT performed >15 min a

10 Technetium-99m-sestamibi has recently been validated as

11 gnostic performance of parathyroid 4D CT and technetium 99m-sestamibi (hereafter, referred to as sest

12 y and gamma imaging after a 740-mBq (20-mCi) technetium 99m sestamibi injection.

13 ommended dose of 740-1100 MBq (20-30 mCi) of technetium 99m-sestamibi is estimated to involve an LAR

14 Parathyroid imaging using technetium-99m sestamibi (MIBI) has evolved and can loca

15 ts who underwent rest thallium-201/adenosine technetium-99m sestamibi MPS, 254 (4.1%) were lost to fo

16 wall thickening from three-dimensional gated technetium-99m sestamibi myocardial perfusion single-pho

17 assess the diagnostic efficacy of adenosine technetium-99m sestamibi myocardial perfusion single-pho

18 rfusion imaging with thallium-201 (n=173) or technetium-99m sestamibi (n=72) and either dipyridamole

19 r injection with 25-30 mCi (925-1110 MBq) of technetium 99m sestamibi, patients were imaged with a hi

20 n fractions can be obtained from gated SPECT technetium-99m sestamibi perfusion images using the imag

21 cy compared with that of ultrasonography and technetium 99m sestamibi scanning may be sufficient to a

22 Same-day rest and dipyridamole technetium-99m sestamibi single photon emission computed

23 either cardiac magnetic resonance imaging or technetium-99m sestamibi single-photon emission computed

24 easurement of infarct size by serum markers, technetium-99m sestamibi single-photon emission computed

25 cise variables of rest thallium-201/exercise technetium-99m sestamibi single-photon emission computed

26 cardiac magnetic resonance (CMR) imaging or technetium-99m sestamibi single-photon emission computed

27 size with cardiac marker release patterns or technetium-99m-sestamibi single-photon emission computed

28 ribution thallium-201 imaging and dobutamine technetium-99m sestamibi SPECT imaging.

29 Infarct size, measured by CMR or technetium-99m sestamibi SPECT within 1 month after prim

30 the ability of early perfusion imaging using technetium-99m sestamibi to predict adverse cardiac outc

31 s on the functional uptake of a radiotracer, technetium 99m sestamibi, to reveal cancers that are occ

32 was measured in a subset of 243 patients by technetium-99m sestamibi tomography.

33 Technetium-99m sestamibi uptake after injection at rest

34 Technetium-99m sestamibi uptake was not significantly di

35 was performed on the stress distribution of technetium-99m sestamibi, using eight frames per cardiac

36 A drawn dose of 8 mCi (296 MBq) of technetium 99m sestamibi was administered to all patient

37 Technetium-99m sestamibi was injected 3 min after the co

38 Technetium-99m-sestamibi was injected intravenously at p